KIAA0101 has been described as a potent oncogene in many cancers (Hosokawa et al., 2007; Zhu et al., 2013) and has been categorized as an anaphase promoting protein (Emanuele et al., 2011). The gene discussed is PCLAF; the disease is cancer.